PT UBC Medical Indonesia Tbk (ISX:LABS) ROA %: 0.00% (As of . 20)


What is PT UBC Medical Indonesia Tbk ROA %?

PT UBC Medical Indonesia Tbk ISX:LABS -0.71% ROA % is 0.00% as of . 20. The stock has 2 warning signs investors should review. Among 857 Medical Devices & Instruments companies, PT UBC Medical Indonesia Tbk ranks worse than 116686% on this metric.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. PT UBC Medical Indonesia Tbk's annualized Net Income for the quarter that ended in . 20 was Rp Mil. PT UBC Medical Indonesia Tbk's average Total Assets over the quarter that ended in . 20 was Rp 0 Mil. Therefore, PT UBC Medical Indonesia Tbk's annualized ROA % for the quarter that ended in . 20 was Not Available.

The historical rank and industry rank for PT UBC Medical Indonesia Tbk's ROA % or its related term are showing as below:

ISX:LABS's ROA % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.54
* Ranked among companies with meaningful ROA % only.

PT UBC Medical Indonesia Tbk  (ISX:LABS) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

Note: The Net Income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


PT UBC Medical Indonesia Tbk ROA % Related Terms


PT UBC Medical Indonesia Tbk ROA % Historical Data

* Premium members only.

The historical data trend for PT UBC Medical Indonesia Tbk's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT UBC Medical Indonesia Tbk ROA % Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
ROA %

PT UBC Medical Indonesia Tbk Semi-Annual Data
ROA %

ISX:LABS vs ABT, SYK, MDT: ROA % Comparison

For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT UBC Medical Indonesia Tbk ROA % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's ROA % distribution charts can be found below:

* The bar in red indicates where PT UBC Medical Indonesia Tbk's ROA % falls into.



PT UBC Medical Indonesia Tbk ROA % Calculation

PT UBC Medical Indonesia Tbk's annualized ROA % for the fiscal year that ended in . 20 is calculated as:

ROA %=Net Income (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

PT UBC Medical Indonesia Tbk's annualized ROA % for the quarter that ended in . 20 is calculated as:

ROA %=Net Income (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (. 20) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of 0.00% mean?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a ROA % of 0.00% as of . 20. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PT UBC Medical Indonesia Tbk and its competitors. According to the industry distribution chart, PT UBC Medical Indonesia Tbk ranks #999999 out of 857 companies in the Medical Devices & Instruments industry.
Is PT UBC Medical Indonesia Tbk's ROA % too high?
PT UBC Medical Indonesia Tbk's current ROA % is 0.00%. Based on the distribution chart, PT UBC Medical Indonesia Tbk ranks #999999 out of 857 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does PT UBC Medical Indonesia Tbk's ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT UBC Medical Indonesia Tbk ranks #999999 out of 857 companies for ROA %. This places PT UBC Medical Indonesia Tbk in the lower half of its industry. The industry median ROA % is 0.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.54, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PT UBC Medical Indonesia Tbk and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT UBC Medical Indonesia Tbk's current ROA % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current ROA % of 0.00%. The current ROA % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current ROA % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT UBC Medical Indonesia Tbk Business Description

Address Jl. Rawagelam V, Blok L, No Kav 11-13, Kantor Pusat, Kawasan Industri Pulogadung, Kel. Jatinegara Kec. Cakung, Jakarta Timur, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.